Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED Post author: Post published:May 6, 2026 Post category: Continue ReadingTrial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED
Stem Cell Therapy for Limbal Stem Cell Deficiency Post author: Post published:April 20, 2026 Post category: Continue ReadingStem Cell Therapy for Limbal Stem Cell Deficiency
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration Post author: Post published:April 20, 2026 Post category: Continue ReadingA Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
CNS10-NPC for the Treatment of RP Post author: Post published:April 20, 2026 Post category: Continue ReadingCNS10-NPC for the Treatment of RP
A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy) Post author: Post published:April 20, 2026 Post category: Continue ReadingA Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)
Stem Cell Therapy for Limbal Stem Cell Deficiency Post author: Post published:March 25, 2026 Post category: Continue ReadingStem Cell Therapy for Limbal Stem Cell Deficiency
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration Post author: Post published:March 25, 2026 Post category: Continue ReadingA Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
CNS10-NPC for the Treatment of RP Post author: Post published:March 1, 2026 Post category: Continue ReadingCNS10-NPC for the Treatment of RP
A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy) Post author: Post published:March 1, 2026 Post category: Continue ReadingA Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)
